HealthEquity, Inc. (NASDAQ:HQY) Stock Holdings Lessened by Next Century Growth Investors LLC

Next Century Growth Investors LLC reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 35.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 75,521 shares of the company’s stock after selling 41,202 shares during the period. Next Century Growth Investors LLC’s holdings in HealthEquity were worth $7,246,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of HQY. EP Wealth Advisors LLC acquired a new position in HealthEquity in the third quarter worth approximately $340,000. Public Employees Retirement System of Ohio increased its stake in shares of HealthEquity by 5.6% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 91,754 shares of the company’s stock worth $7,510,000 after purchasing an additional 4,878 shares during the last quarter. Barclays PLC raised its holdings in shares of HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock valued at $13,628,000 after purchasing an additional 112,667 shares in the last quarter. M&T Bank Corp lifted its stake in shares of HealthEquity by 0.7% in the 3rd quarter. M&T Bank Corp now owns 49,447 shares of the company’s stock valued at $4,047,000 after purchasing an additional 321 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in HealthEquity by 0.7% in the third quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock worth $170,197,000 after purchasing an additional 15,145 shares in the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Price Performance

Shares of HQY opened at $82.20 on Friday. The stock has a 50 day simple moving average of $97.63 and a 200 day simple moving average of $96.30. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market capitalization of $7.11 billion, a PE ratio of 75.41, a P/E/G ratio of 1.60 and a beta of 0.49.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on HQY shares. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Barrington Research reaffirmed an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a report on Friday. Wells Fargo & Company lifted their target price on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. The Goldman Sachs Group cut their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. Finally, KeyCorp reduced their target price on HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Monday, March 24th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, HealthEquity currently has an average rating of “Buy” and a consensus target price of $112.58.

Insider Activity

In related news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company’s stock, valued at approximately $4,433,820.30. This trade represents a 13.55 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares in the company, valued at $6,597,842.85. The trade was a 6.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,381 shares of company stock worth $1,781,432 over the last quarter. 2.20% of the stock is currently owned by company insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.